Abstract
Purpose
As a common head and neck tumor, laryngeal cancer has attracted heightened attention for its treatment and prognosis. Surgery and radiotherapy were mainly therapeutic approaches in laryngeal cancer, and intensity-modulated radiotherapy (IMRT) was a precision treatment way in radiotherapy. However, the therapeutic effect of surgery plus IMRT in laryngeal cancer was rarely reported. This study aims to determine the effect of IMRT on the treatment of patients with laryngeal cancer.
Methods
A total of 125 patients with laryngeal cancer were collected and retrospectively analyzed based on their clinical data and follow-up results. These patients had a clear treatment plan for surgery and intensity-modulated radiotherapy.
Results
Smoking, lymph node metastasis, TNM staging and therapeutic approaches could affect the survival of patients with laryngeal cancer. It was shown that the laryngeal function retention rate in the simple IMRT group was significantly higher than the simple surgery group and surgery plus IMRT group. The 5-year survival rate of surgery plus IMRT, simple surgery and simple IMRT were 82.86%, 53.85% and 43.33%, respectively. The locoregional recurrences rate of surgery plus IMRT, simple surgery and simple IMRT were 14.29%, 34.62% and 43.33%.
Conclusion
Surgery plus IMRT was a feasible and efficacious treatment technique for patients with laryngeal cancer, which effectively prolong the survival time of patients.
Similar content being viewed by others
Availability of data and materials
The data used to support the findings of this study are available from the corresponding author upon request.
References
Atef A, El-Rashidy MA, Elzayat S, Kabel AM (2019) The prognostic value of sex hormone receptors expression in laryngeal carcinoma. Tissue Cell 57:84–89
Bandhary SK, Shetty V, Saldanha M, Gatti P, Devegowda DRPS, Shetty AK (2018) Detection of human papilloma virus and risk factors among patients with head and neck squamous cell carcinoma attending a tertiary referral Centre in South India. APJCP. 19(5):1325–1330
Calkovsky V, Wallenfels P, Calkovska A, Hajtman A (2016) Laryngeal cancer: 12-year experience of a single center. Adv Exp Med Biol 911:9–16
Chen L, Song Y, Zhang Y, Chen M, Chen J (2018) Exploration of the exact prognostic significance of lymphatic metastasis in jejunoileal neuroendocrine tumors. Ann Surg Oncol 25(7):2067–2074
Chen L, Qian K, Guo K, Zheng X, Sun W, Sun T, Wang Y, Li D, Wu Y, Ji Q, Wang Z (2019) A novel N staging system for predicting survival in patients with medullary thyroid cancer. Ann Surg Oncol 26(13):4430–4438
Fondevilla Soler A, López-Guerra JL, García Fernández A, Samaniego Conde MA, Belmonte González MJ, Praena-Fernandez JM, Rivin Del Campo E, Alcaraz M, Azinovic I (2019) Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer. Clin Transl Oncology 21(7):881–890
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS (2013) Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852
Forastiere AA, Ismaila N, Wolf GT (2018) Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary. J Oncol Pract 14(2):123–128
Hashim D, Sartori S, La Vecchia C, Serraino D, Maso LD, Negri E, Smith E, Levi F, Boccia S, Cadoni G, Luu HN, Lee YA, Hashibe M, Boffetta P (2017) Hormone factors play a favorable role in female head and neck cancer risk. Cancer Med 6(8):1998–2007
He Y, Liang D, Li D, Shan B, Zheng R, Zhang S, Wei W, He J (2020) Incidence and mortality of laryngeal cancer in China, 2015. Chin J Cancer Res 32(1):10–17
Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS (2018) Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer. JAMA Oncol 4(7):985–989
Hu Y, Deng K, Pan M, Liu S, Li W, Huang J, Yao J, Zuo J (2020) Down-regulation of PCK2 inhibits the invasion and metastasis of laryngeal carcinoma cells. Am J Transl Res 12(7):3842–3857
Huang L, Jansen L, Balavarca Y, van der Geest L, Lemmens V, Groot Koerkamp B, van Santvoort HC, Grützmann R, Besselink MG, Schrotz-King P, Brenner H (2019) Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I–II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study. Ann Surg
Huh G, Ahn SH, Suk JG, Lee MH, Kim WS, Kwon SK, Ock CY, Keam B, Heo DS, Kim JH, Wu HG (2020) Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer. Jpn J Clin Oncol 50(2):185–192
Iorio GC, Martini S, Arcadipane F, Ricardi U, Franco P (2019) The role of radiotherapy in epithelial ovarian cancer: a literature overview. Med Oncol (Northwood, London, England) 36(7):64
Kabarriti R, Brodin NP, Ahmed S, Vogelius I, Guha C, Kalnicki S, Tomé WA, Garg MK (2019) Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging. Cureus 11(1):e3856
Karatzanis AD, Psychogios G, Waldfahrer F, Kapsreiter M, Zenk J, Velegrakis GA, Iro H (2014) Management of locally advanced laryngeal cancer. J Otolaryngol Head Neck Surg 43(1):4
Lei DP, Pan XL (2019) Treatment options for advanced laryngeal carcinoma. Chin J Otorhinolaryngol Head Neck Surg 54(5):398–400
Li S, Li J, Hu T, Zhang C, Lv X, He S, Yan H, Tan Y, Wen M, Lei M, Zuo J (2017) Bcl-2 overexpression contributes to laryngeal carcinoma cell survival by forming a complex with Hsp90β. Oncol Rep 37(2):849–856
Li Y, Zhao W, Ni J, Zou L, Yang X, Yu W, Fu X, Zhao K, Zhang Y, Chen H, Xiang J, Xie C, Zhu Z (2019) Predicting the value of adjuvant therapy in esophageal squamous cell carcinoma by combining the total number of examined lymph nodes with the positive lymph node ratio. Ann Surg Oncol 26(8):2367–2374
Liang W, He J, Shen Y, Shen J, He Q, Zhang J, Jiang G, Wang Q, Liu L, Gao S, Liu D, Wang Z, Zhu Z, Ng CS, Liu CC, Horsleben Petersen R, Rocco G, D’Amico T, Brunelli A, Chen H, Zhi X, Liu B, Yang Y, Chen W, Zhou Q, He J (2017) Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER Database and a Chinese Multi-Institutional Registry. J Clin Oncol 35(11):1162–1170
Megwalu UC, Panossian H (2016) Survival outcomes in early stage laryngeal cancer. Anticancer Res 36(6):2903–2907
Nocini R, Molteni G, Mattiuzzi C, Lippi G (2020) Updates on larynx cancer epidemiology. Chin J Cancer Res 32(1):18–25
Petrarolha S, Dedivitis R, Matos L, Ramos D, Kulcsar M (2020) Lymph node density as a predictive factor for worse outcomes in laryngeal cancer. Eur Arch Oto-rhino-laryngol 277(3):833–840
Souza FGR, Santos IC, Bergmann A, Thuler LCS, Freitas AS, Freitas EQ, Dias FL (2020) Quality of life after total laryngectomy: impact of different vocal rehabilitation methods in a middle income country. Health Qual Life Outcomes 18(1):92
Zhu X, Heng Y, Zhou L, Tao L, Zhang M (2019) A prognostic nomogram for predicting risk of recurrence in laryngeal squamous cell carcinoma patients after tumor resection to assist decision making for postoperative adjuvant treatment. J Surg Oncol 120(4):698–706
Zhu X, Zhao M, Zhou L, Zhang M, Cao P, Tao L (2020) Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma. Cancer Med 9(9):3006–3014
Zuo J, Wen M, Lei M, Peng X, Yang X, Liu Z (2015) MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer. J Cell Biochem 116(6):1039–1049
Funding
This work is supported by the Key Research Program from the Science and Technology Department of Ningxia Hui Autonomous Region, China (2019BFH02012) and the Key Research Program of Hunan Health Committee (20201909), the Program of Hengyang science and Technology Bureau (2017-1, 2020-67), and the Program of Shaoyang science and Technology Bureau (2018FJ19).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by JY, SZ, MW, JH and TZ. The first draft of the manuscript was written by KD and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethics approval
This study was approved by the Ethics Committee of the First Affiliated Hospital of University of South China. Informed consent from patients was obtained prior to enrollment.
Informed consent
As stated in the ethical approval section, each patient provided written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Deng, K., Yao, J., Zeng, S. et al. The effect of surgery plus intensity-modulated radiotherapy on treatment in laryngeal cancer: A clinical retrospective study. J Cancer Res Clin Oncol 148, 517–525 (2022). https://doi.org/10.1007/s00432-021-03637-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-021-03637-z